The Commission for Protection of Competition in Bulgaria has approved Sopharma Trading (SO5 BU)’s acquisition of the local PharmaStore harmacies chain. The Regulator’s decision comes after the company announced in March this year that it has reached the agreement for the acquisition of PharmaStore pharmacies operations (19 pharmacies in Bulgaria), with the intention of subsequently integrating them into the SOpharmacy chain. The acquisition will strengthen Sopharma Trading’s retail market presence.
Sopharma Trading expands in Serbia
In July 2017, the Commission for Protection of Competition in Serbia has approved Sopharma Trading to acquire the majority shares of Lekovit company – the fastest growing pharmaceutical wholesaler in Serbia in the last 3 years. The Regulator’s decision came a few weeks after the two companies announced their partnership intentions.
Under the arrangements the current shareholder in Lekovit, Dr. Dragan Petrovic, will keep the minority shares and will continue contributing to the further development of the company on the CEO position.
Earlier this year Sopharma Trading scheduled extraordinary general meeting to get debt financing approved – fueling expansion plans.
Shareholders approved new debt financing from various banks for a total of approx. BGN 54m to be used for acquisitions in Bulgaria and Serbia.